The impact of gastrointestinal mucus on nanoparticle penetration – in vitro evaluation of mucus-penetrating nanoparticles for photodynamic therapy
- 1 May 2019
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 133, 28-39
Abstract
No abstract availableKeywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (13N13423)
This publication has 40 references indexed in Scilit:
- Mucus-penetrating nanoparticles: Promising drug delivery systems for the photodynamic therapy of intestinal cancerEuropean Journal of Pharmaceutics and Biopharmaceutics, 2018
- Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrierAdvanced Drug Delivery Reviews, 2016
- Mucus as a Barrier to Drug Delivery – Understanding and Mimicking the Barrier PropertiesBasic & Clinical Pharmacology & Toxicology, 2014
- A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedureEuropean Journal of Pharmaceutics and Biopharmaceutics, 2014
- Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2013
- In Vitro Study of Intestinal Transport of Inorganic and Methylated Arsenic Species by Caco-2/HT29-MTX CoculturesChemical Research in Toxicology, 2012
- Photodynamic therapy of cancer: An updateCA: A Cancer Journal for Clinicians, 2011
- Defining conditions for the co-culture of Caco-2 and HT29-MTX cells using Taguchi designJournal of Pharmacological and Toxicological Methods, 2010
- Nanoparticles in photodynamic therapy: An emerging paradigmAdvanced Drug Delivery Reviews, 2008
- Transport of Lipophilic Drug Molecules in a New Mucus-Secreting Cell Culture Model Based on HT29-MTX CellsPharmaceutical Research, 2001